Journals / Türk Kardiyoloji Derneği Arşivi / 2007 / Cilt: 35 - Sayı: 5

Akut koroner sendromlu hastalarda koroner arter hastalığının ciddiyeti ile interlökin-6 polimorfizmi arasındaki ilişki

The relationship between interleukin-6 polymorphism and the extent of coronary artery disease in patients with acute coronary syndrome

Pages
278–283
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: Patients with less extensive CAD had a significantly lower prevalence of positive familial CAD and significantly lower plasma IL-6 and fibrinogen levels compared to those with extensive CAD (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: We investigated plasma fibrinogen and interleukin-6 (IL-6) levels and the frequency of IL-6 polymorphism in patients with acute coronary syndrome.
📊
Key Findings & Data:Study design: A case-control study was conducted in 115 patients who underwent coronary angiography for suspected ischemic heart disease.
💡
Conclusion & Impact:Results: Patients with less extensive CAD had a significantly lower prevalence of positive familial CAD and significantly lower plasma IL-6 and fibrinogen levels compared to those with extensive CAD (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: We investigated plasma fibrinogen and interleukin-6 (IL-6) levels and the frequency of IL-6 polymorphism in patients with acute coronary syndrome. Study design: A case-control study was conducted in 115 patients who underwent coronary angiography for suspected ischemic heart disease. The patients were classified into two groups according to angiography findings: 65 patients (49 males, 16 females; mean age 61±10 years) had less extensive coronary artery disease (CAD) (1-vessel stenosis), and 50 patients (36 males, 14 females; mean age 61±9 years) had extensive CAD (≥2-vessel stenosis). Fasting blood samples were taken to determine serum lipids, high sensitivity C-reactive protein, IL-6, and fibrinogen levels. The genotypic distribution and the IL-6 C/G-174 polymorphism were determined by polymerase chain reaction. Results: Patients with less extensive CAD had a significantly lower prevalence of positive familial CAD and significantly lower plasma IL-6 and fibrinogen levels compared to those with extensive CAD (p

Özet

Amaç: Bu çalışmada akut koroner sendromlu hastalarda plazma fibrinojen ve interlökin-6 (IL-6) düzeyleri ile IL-6 polimorfizmi sıklığı araştırıldı.Çalışma planı: İskemik kalp hastalığı şüphesiyle koroner anjiyografi ile incelenen 115 hasta üzerinde olgu-kontrol çalışması yapıldı. Anjiyografi bulgularına göre hastalar iki grupta değerlendirildi: 65 hastada (49 erkek, 16 kadın; ort. yaş 61±10) sınırlı koroner arter hastalığı (KAH) (1 damar daralmış), 50 hastada (36 erkek, 14 kadın; ort. yaş 61±9) yaygın KAH (≥2 damar daralmış) vardı. Hastalardan açlık kan örnekleri alınarak serum lipidleri, yüksek duyarlıklı C-reaktif protein, IL-6, ve fibrinojen düzeyleri ölçüldü. İki grupta genotipik dağılım ve IL-6 C/G-174 polimorfizmi varlığı polimeraz zincir reaksiyonuyla belirlendi. Bulgular: Sınırlı KAH bulunan grupta KAH için pozitif aile öyküsü anlamlı derecede düşük oranda bulundu; ayrıca, plazma IL-6 ve fibrinojen düzeyleri de yaygın KAH bulunan gruba göre anlamlı derecede düşük idi (p

🔖

Cite This Article

KARAKELLEOĞLU, Ş., ÖZDEMİR, Ö., SERDAR, S., PİRİM, İ., AÇIKEL, M., SEVİMLİ, S., GÜNDOĞDU, F., ARSLAN, Ş. (2022). Akut koroner sendromlu hastalarda koroner arter hastalığının ciddiyeti ile interlökin-6 polimorfizmi arasındaki ilişki. Türk Kardiyoloji Derneği Arşivi, Cilt: 35 - Sayı: 5, 278–283. https://ajindex.com/articles/633592

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999;340:115-26
  2. Romano M, Sironi M, Toniatti C, Polentarutti N, Fruscella P, Ghezzi P, et al. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 1997;6:315-25
  3. Dalmon J, Laurent M, Courtois G. The human beta fibrinogen promoter contains a hepatocyte nuclear factor 1-dependent interleukin-6-responsive element. Mol Cell Biol 1993;13:1183-93
  4. Ridker PM, Glynn RJ, Hennekens CH. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 1998;97:2007-11
  5. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000;101:1767-72
  6. Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 1998;351:88-92
  7. Lindmark E, Diderholm E, Wallentin L, Siegbahn A. Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy. JAMA 2001;286:2107-13
  8. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994;331:417-24
  9. Haim M, Tanne D, Boyko V, Reshef T, Goldbourt U, Leor J, et al. Soluble intercellular adhesion molecule-1 and long-term risk of acute coronary events in patients with chronic coronary heart disease. Data from the Bezafibrate Infarction Prevention (BIP) Study. J Am Coll Cardiol 2002;39:1133 8
  10. Meade TW, North WR, Chakrabarti R, Stirling Y, Haines AP, Thompson SG, et al. Haemostatic function and cardiovascular death: early results of a prospective study. Lancet 1980;1:1050-4
  11. Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WR, et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986;2:533-7
  12. Biasucci LM, Vitelli A, Liuzzo G, Altamura S, Caligiuri G, Monaco C, et al. Elevated levels of interleukin-6 in unstable angina. Circulation 1996;94:874-7
  13. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, et al. The effect of novel polymorphisms in the interleu